Skip to main content
The British Journal of Venereal Diseases logoLink to The British Journal of Venereal Diseases
. 1982 Jun;58(3):176–179. doi: 10.1136/sti.58.3.176

Single oral dose of cefaclor for the treatment of infections with penicillinase-producing strains of Neisseria gonorrhoeae.

T E Tupasi, O V Calubiran, C A Torres
PMCID: PMC1046039  PMID: 6805850

Abstract

A single oral dose of 3 g cefaclor was effective in the treatment of uncomplicated gonococcal infection in women due to penicillinase-producing strains of Neisseria gonorrhoeae (PPNG). Cefaclor was equally active in vitro against both PPNG (MIC range, 0.01-1.0 microgram/ml) and non-PPNG strains (MIC range, 0.005-2.0 micrograms/ml). As empirical treatment cefaclor was effective in 53 of 57 (93%) patients compared with ampicillin, to which only 37 of 53 (69.8%) patients responded. This difference was attributed to the 40% incidence of PPNG in the patients studied; as expected, such patients responded poorly to ampicillin.

Full text

PDF
177

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Thornsberry C., Jones R. N., Fuchs P. C., Gavan T. L., Gerlach E. H. Cefuroxime, an in vitro Comparison with Six Other Cephalosporins. Proc R Soc Med. 1977;70(Suppl 9):63–71. [PMC free article] [PubMed] [Google Scholar]
  2. Berg S. W., Kilpatrick M. E., Harrison W. O., McCutchan J. A. Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae. N Engl J Med. 1979 Sep 6;301(10):509–511. doi: 10.1056/NEJM197909063011001. [DOI] [PubMed] [Google Scholar]
  3. Biddle J. W., Swenson J. M., Thornsberry C. Disc agar diffusion antimicrobial susceptibility tests with beta-lactamase producing Neisseria gonorrhoeae. J Antibiot (Tokyo) 1978 Apr;31(4):352–358. doi: 10.7164/antibiotics.31.352. [DOI] [PubMed] [Google Scholar]
  4. Catlin B. W. Iodometric detection of Haemophilus influenzae beta-lactamase: rapid presumptive test for ampicillin resistance. Antimicrob Agents Chemother. 1975 Mar;7(3):265–270. doi: 10.1128/aac.7.3.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hall W. H., Schierl E. A., Maccani J. E. Comparative susceptibility of penicillinase-positive and -negative Neisseria gonorrhoeae to 30 antibiotics. Antimicrob Agents Chemother. 1979 Apr;15(4):562–567. doi: 10.1128/aac.15.4.562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hodges G. R., Liu C., Hinthorn D. R., Harms J. L., Dworzack D. L. Pharmacological evaluation of cefaclor in volunteers. Antimicrob Agents Chemother. 1978 Sep;14(3):454–456. doi: 10.1128/aac.14.3.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. O'Callaghan C. H., Kirby S. M., Morris A., Waller R. E., Duncombe R. E. Correlation between hydrolysis of the -lactam bond of the cephalosporin nucleus and expulsion of the 3-substituent. J Bacteriol. 1972 Jun;110(3):988–991. doi: 10.1128/jb.110.3.988-991.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Oller L. Z., Smith H. G., Marshall M. J. Cephaloridine and cephalexin in venereological practice. Postgrad Med J. 1970 Oct;(Suppl):99–102. [PubMed] [Google Scholar]
  9. Silver M. S., Counts G. W., Zeleznik D., Turck M. Comparison of in vitro antibacterial activity of three oral cephalosporins: cefaclor, cephalexin, and cephradine. Antimicrob Agents Chemother. 1977 Nov;12(5):591–596. doi: 10.1128/aac.12.5.591. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Spagna V. A., Perkins R. L., Prior R. B. Successful treatment with cefaclor of gonococcal urethritis in men. Sex Transm Dis. 1979 Jul-Sep;6(3):211–213. doi: 10.1097/00007435-197907000-00005. [DOI] [PubMed] [Google Scholar]
  11. Willcox R. R., Woodcock K. S. Cephalexin in the oral treatment of gonorrhoea by a double-dose method. Postgrad Med J. 1970 Oct;(Suppl):103–106. [PubMed] [Google Scholar]
  12. Wise R., Andrews J. M., Dean S., Welling P. G., Kendall M. J. A pharmacological and in vitro comparison of three oral cephalosporins. J Antimicrob Chemother. 1979 Sep;5(5):601–607. doi: 10.1093/jac/5.5.601. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Venereal Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES